These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26543110)

  • 21. Understanding the role of Propionibacterium acnes in acne vulgaris: The critical importance of skin sampling methodologies.
    Omer H; McDowell A; Alexeyev OA
    Clin Dermatol; 2017; 35(2):118-129. PubMed ID: 28274348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acne vaccines targeting Propionibacterium acnes.
    Kao M; Huang CM
    G Ital Dermatol Venereol; 2009 Dec; 144(6):639-43. PubMed ID: 19907403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
    Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
    J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics of the Propionibacterium strains isolated from acne patients].
    Białecka A; Kasprowicz A; Kaszycki P; Marcinkiewicz J
    Med Dosw Mikrobiol; 2004; 56(1):79-92. PubMed ID: 15524399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuraminidase production by Propionibacterium acnes-strains isolated from patients with acne vulgaris, seborrheic eczema and healthy subjects.
    Höffler U; Gloor M; von Nicolai H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):122-6. PubMed ID: 6458977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Anti-Inflammatory Activities of Propionibacterium acnes CAMP Factor-Targeted Acne Vaccines.
    Wang Y; Hata TR; Tong YL; Kao MS; Zouboulis CC; Gallo RL; Huang CM
    J Invest Dermatol; 2018 Nov; 138(11):2355-2364. PubMed ID: 29964032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights in the pathogenic potential of Propionibacterium acnes from its complete genome.
    Brüggemann H
    Semin Cutan Med Surg; 2005 Jun; 24(2):67-72. PubMed ID: 16092793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biotyping of Propionibacterium acnes strains isolated from patients with acne vulgaris].
    Ergin C; Kaleli I; Sahin R; Ergin S; Kaçar N
    Mikrobiyol Bul; 2006; 40(1-2):15-21. PubMed ID: 16775952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity.
    Jasson F; Nagy I; Knol AC; Zuliani T; Khammari A; Dréno B
    Exp Dermatol; 2013 Sep; 22(9):587-92. PubMed ID: 23947673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acne and Propionibacterium acnes.
    Bojar RA; Holland KT
    Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutibacterium acnes Type II strains are associated with acne in Chinese patients.
    Zhao S; Ci J; Xue J; Wang Y; Li X; Hao L; Tian L; Guo H; Xin C; Zhao Y
    Antonie Van Leeuwenhoek; 2020 Mar; 113(3):377-388. PubMed ID: 31630297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of distribution patterns of Propionibacterium acnes phylotypes and Peptostreptococcus species from acne lesions.
    Kwon HH; Yoon JY; Park SY; Suh DH
    Br J Dermatol; 2013 Nov; 169(5):1152-5. PubMed ID: 23795647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates.
    Dréno B; Pécastaings S; Corvec S; Veraldi S; Khammari A; Roques C
    J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():5-14. PubMed ID: 29894579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Typing of Propionibacterium acnes: a review of methods and comparative analysis.
    Yu Y; Champer J; Garbán H; Kim J
    Br J Dermatol; 2015; 172(5):1204-9. PubMed ID: 25600912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of hyaluronidase by propionibacteria from different origins.
    Höffler U
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):123-9. PubMed ID: 44604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan.
    Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N
    J Med Microbiol; 2014 May; 63(Pt 5):721-728. PubMed ID: 24523159
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    McLaughlin J; Watterson S; Layton AM; Bjourson AJ; Barnard E; McDowell A
    Microorganisms; 2019 May; 7(5):. PubMed ID: 31086023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotype and Antimicrobial Activity of Th17 Cells Induced by Propionibacterium acnes Strains Associated with Healthy and Acne Skin.
    Agak GW; Kao S; Ouyang K; Qin M; Moon D; Butt A; Kim J
    J Invest Dermatol; 2018 Feb; 138(2):316-324. PubMed ID: 28864077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activities of azole antifungal agents against Propionibacterium acnes isolated from patients with acne vulgaris.
    Sugita T; Miyamoto M; Tsuboi R; Takatori K; Ikeda R; Nishikawa A
    Biol Pharm Bull; 2010; 33(1):125-7. PubMed ID: 20045949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.